Document is current

Article History

Received: 11 January 2022

Accepted: 29 July 2022

First Online: 13 August 2022

Declarations

:

: The studies involving human participants were reviewed and approved by the Ethics Committee of Yuebei People’s Hospital of Shaoguan. All methods were carried out in accordance with relevant guidelines and regulations. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially data included in this article.

: Not applicable.

: Hongbo Zheng was employed by Genecast Biotechnology Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.